glucosamine has been researched along with Dermatitis, Atopic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheong, KA; Kim, CH; Lee, AY; Park, CD | 2 |
| Ahn, BJ; Cheong, KA; Choi, Y; Jin, SY; Kwon, HB; Lee, AY; Lee, J | 1 |
| Cheong, KA; Choi, YS; Kim, CH; Lee, AY | 1 |
1 trial(s) available for glucosamine and Dermatitis, Atopic
| Article | Year |
|---|---|
Combination of glucosamine improved therapeutic effect of low-dose cyclosporin A in patients with atopic dermatitis: a pilot study.
Topics: Adolescent; Adult; Cross-Over Studies; Cyclosporine; Dermatitis, Atopic; Drug Therapy, Combination; Female; Glucosamine; Humans; Interferon-gamma; Interleukin-4; Leukocytes, Mononuclear; Linear Models; Male; Pilot Projects; Severity of Illness Index; Young Adult | 2013 |
3 other study(ies) available for glucosamine and Dermatitis, Atopic
| Article | Year |
|---|---|
Glucosamine improved atopic dermatitis-like skin lesions in NC/Nga mice by inhibition of Th2 cell development.
Topics: Animals; CD4-Positive T-Lymphocytes; Cell Differentiation; Cytokines; Dermatitis, Atopic; GATA3 Transcription Factor; Glucosamine; Histocytochemistry; Immunoglobulin E; Immunosuppressive Agents; Male; Mice; Pyroglyphidae; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; T-Box Domain Proteins; Th2 Cells | 2011 |
Therapeutic effects of combination using glucosamine plus tacrolimus (FK-506) on the development of atopic dermatitis-like skin lesions in NC/Nga mice.
Topics: Animals; CD3 Complex; Chemokine CCL11; Chemokine CCL17; Chemokines; Cytokines; Dermatitis, Atopic; Dermatophagoides farinae; Disease Models, Animal; Drug Therapy, Combination; Eosinophils; Glucosamine; Immunoglobulin E; Immunosuppressive Agents; Interleukin-13; Interleukin-5; Male; Mast Cells; Mice; Scavenger Receptors, Class B; Skin; Tacrolimus; Th2 Cells | 2012 |
Mechanism underlying the effect of combined therapy using glucosamine and low-dose cyclosporine A on the development of atopic dermatitis-like skin lesions in NC/Nga mice.
Topics: Animals; Antigens, Dermatophagoides; CD4 Antigens; Cells, Cultured; Cyclosporine; Cytokines; Dermatitis, Atopic; Dermatophagoides farinae; Drug Dosage Calculations; Drug Therapy, Combination; Eosinophils; Filaggrin Proteins; Glucosamine; Humans; Immunoglobulin E; Immunosuppressive Agents; Interleukin-2 Receptor alpha Subunit; Intermediate Filament Proteins; Keratins; Male; Mast Cells; Mice; Mice, Inbred Strains; Skin; T-Lymphocytes, Regulatory; Th1-Th2 Balance | 2013 |